Vasoptic Medical Inc., a Baltimore-based medical technology company, raised $1.5 million in a private equity offering, according to a filing with the Securities and Exchange Commission.

Vasoptic Medical filed a Form D on April 7. It did not disclose what it intended to do with the proceeds.

The company was founded in 2012 by M. Jason Brooke and Abhishek Rege based on technology developed by Rege while studying at Johns Hopkins University.

A Video Conversation with M. Jason Brooke, CEO of Vasoptic Medical Inc.

The technology is a portable retinal imager that examines retinal microvasculature and is making a significant impact on the prevention of vision loss associated with diabetes.

It has implemented its product in primary care and community clinics. It is low-cost and easy to use technique that monitors the progression of various metrics that are commonly found in retinal diseases.

The Maryland Technology Development Corp. chose Vasoptic Medical for financial investment from the Life Science Investment Fund in 2016. Companies chosen by TEDCO are given an investment of up to $200,000 in order to advance their products commercialization.